ERYTECH reports financial highlights for Q3 2015 Post author:admERY Post published:November 3, 2015 Post category:Newsroom ERYTECH reports cash balance and revenues for the third quarter of 2015. You Might Also Like ERYTECH Presents New Preclinical Anti-Tumor Data on erymethionase at AACR 2017 March 20, 2017 ERYTECH’s IPO a remarkable success, raising €17.7 million April 30, 2013 ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL April 4, 2017
ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL April 4, 2017
